Analysts: Buy These Biotech Penny Stocks

Citigroup likes SYBX ahead of drug data, and Jefferies weighed in on ARDX

Aug 24, 2018 at 1:33 PM
facebook X logo linkedin


The shares of Synlogic Inc (NASDAQ:SYBX) and Ardelyx Inc (NASDAQ:ARDX) are higher today, after the penny stocks scored upbeat analyst notes. Citigroup upgraded drug concern SYBX to "buy" from "neutral," waxing optimistic on the company's Synthetic Biotic medicine, with data due by the end of the year. ARDX stock, meanwhile, earned a new "buy" rating and $7 price target -- a 70% premium to Thursday's close -- at Jefferies.

Synlogic shares were last seen 9.3% higher to trade at $8.59. The stock is on pace to end north of its 20-day moving average for the first time since late July, but still remains nearly 10% lower month-to-date, after touching an all-time low of $7.27 on Aug. 13. Further, SYBX could run into a potential hurdle in the $9-$9.50 area, which acted as support in the first half of the year.

SYBX stock chart august 24

Meanwhile, it looks like Citigroup is late to the party, as most analysts are already in the bullish camp for Synlogic. The six brokerage firms covering SYBX consider it worthy of a "buy" or better endorsement, and the average 12-month price target of $17.83 is more than double the security's current price.

Ardelyx stock is up 2.4% to trade at $4.25, but has stalled around its formerly supportive 80-day moving average. This trendline was briefly toppled in mid-May, but subsequently breached again after the biotech priced a public stock offering at $4 per share.

ARDX stock chart aug 24

Again, most analysts are already in the bullish camp. All four of the brokerage firms following ARDX consider it a "buy" or better, and the average 12-month price target of $12.29 is nearly triple the equity's current price.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI